Pay in 4 interest-free payments of $36.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
18)/t12-/m1/s1
1999398A3P
086 microM) and the closely related InsR (IC50 = 2
It specifically binds to Hsp90 with an IC50 of 24 nM
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial
TAK-733 0162 18)/t12-/m1/s1TAK 733 is an orally bioavailable small molecule inhibitor of MEK1 and MEK2 (MEK1 2) with potential antineoplastic activity. MEK inhibitor TAK 733 selectively binds to and inhibits the activity of MEK1 2, preventing the activation of MEK1 2 dependent effector proteins and transcription factors, which may result in the inhibition of growth factor mediated cell signaling and tumor cell proliferation. MEK1 2 (MAP2K1 K2) are dual specificity threonine